| Patients with primary immunodeficiencies are a reservoir of poliovirus and a risk to polio eradication A Aghamohammadi, H Abolhassani, N Kutukculer, SG Wassilak, ... Frontiers in immunology 8, 685, 2017 | 60 | 2017 |
| Efficacy and safety of pidotimod in the prevention of recurrent respiratory infections in children: a multicentre study LS Namazova-Baranova, AA Alekseeva, SM Kharit, TN Kozhevnikova, ... International Journal of Immunopathology and Pharmacology 27 (3), 413-419, 2014 | 56 | 2014 |
| Thirty years of primary immunodeficiencies in Turkey O Sanal, I Tezcan Annals of the New York Academy of Sciences 1238 (1), 15-23, 2011 | 51 | 2011 |
| Molecular markers for diagnosis, staging, and prognosis of bladder cancer. SG Williams, M Buscarini, JP Stein Oncology (Williston Park, NY) 15 (11), 1461-70, 1473, 2001 | 41 | 2001 |
| The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment N Rezaei, P Mohammadinejad, A Aghamohammadi Annals of the New York Academy of Sciences 1238 (1), 24-32, 2011 | 36 | 2011 |
| Primary immunodeficiencies in Russia: Data from the national registry AA Mukhina, NB Kuzmenko, YA Rodina, IV Kondratenko, AA Bologov, ... Frontiers in Immunology 11, 1491, 2020 | 34 | 2020 |
| The creation and progress of the J Project in Eastern and Central Europe L Maródi, J Project Study Group Annals of the New York Academy of Sciences 1238 (1), 65-73, 2011 | 31 | 2011 |
| A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival Z Chen, G Liu, A Hossain, IG Danilova, MA Bolkov, G Liu, IA Tuzankina, ... Hereditas 156, 1-11, 2019 | 29 | 2019 |
| Иммунологические аспекты дифференциальной диагностики синдрома гипертиреоза ДА Дрометр, ИА Тузанкина, АВ Кияев Клиническая и экспериментальная тиреоидология 3 (1), 18-23, 2007 | 26 | 2007 |
| Identification of miR-200c and miR141-mediated lncRNA-mRNA crosstalks in muscle-invasive bladder cancer subtypes G Liu, Z Chen, IG Danilova, MA Bolkov, IA Tuzankina, G Liu Frontiers in Genetics 9, 408492, 2018 | 25 | 2018 |
| Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and NBN Founder Variant c … SO Sharapova, OE Pashchenko, AV Bondarenko, SS Vakhlyarskaya, ... Frontiers in Immunology 11, 602482, 2021 | 24 | 2021 |
| Fifteen years of the J Project L Maródi Journal of Clinical Immunology 39, 363-369, 2019 | 21 | 2019 |
| Ведущий механизм иммунопатологического процесса при псориатической болезни НВ Кунгуров, НН Филимонкова, ИА Тузанкина Успехи современного естествознания 2, 73-6, 2002 | 18 | 2002 |
| Анализ клинических проявлений дебюта первичных иммунодефицитов у взрослых ИА Тузанкина, МЛ Каракина, ЕВ Власова Медицинская иммунология 16 (4), 367-374, 2014 | 16 | 2014 |
| Novel disease-associated missense single-nucleotide polymorphisms variants predication by algorithms tools and molecular dynamics simulation of human TCIRG1 gene causing … K Shinwari, HM Rehman, G Liu, MA Bolkov, IA Tuzankina, ... Frontiers in Molecular Biosciences 9, 879875, 2022 | 15 | 2022 |
| Europe immunoglobulin map A Šedivá, H Chapel, A Gardulf Clinical and Experimental Immunology 178 (Suppl 1), 141, 2014 | 14 | 2014 |
| The spread of the J Project Z Horváth, N Rezaei, I Reisli, I Tuzankina, N Otarbayev, P Popandopulo, ... Journal of clinical immunology 33, 1037-1042, 2013 | 14 | 2013 |
| Cytotoxic T lymphocytes mediate neuronal injury in patients with X-linked agammaglobulinemia and progressive neurodegenerative disease. I Tuzankina, Y Kobeleva, N Kiseleva, M Bolkov, G Reuter, L Maródi Allergy 66 (12), 2011 | 13 | 2011 |
| The Konya declaration for patients with primary immunodeficiencies L Maródi Journal of Clinical Immunology 40 (5), 770-773, 2020 | 12 | 2020 |
| Применение полиоксидония в терапии вульгарного псориаза ИА Тузанкина, НН Филимонкова, ЭР Бердникова Иммунология 26 (4), 240-244, 2005 | 12 | 2005 |
